Spontaneous regression of adult T cell leukemia/lymphoma following development of immune thrombocytopenia

Ann Hematol. 2016 Apr;95(5):841-3. doi: 10.1007/s00277-016-2624-z. Epub 2016 Feb 29.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Adrenal Cortex Hormones / administration & dosage
  • Allografts
  • Antineoplastic Combined Chemotherapy Protocols / administration & dosage
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use
  • Benzoates / therapeutic use
  • Carboplatin / administration & dosage
  • Combined Modality Therapy
  • Cyclophosphamide / administration & dosage
  • Doxorubicin / administration & dosage
  • Etoposide / administration & dosage
  • Female
  • Hematopoietic Stem Cell Transplantation
  • Humans
  • Hydrazines / therapeutic use
  • Leukemia-Lymphoma, Adult T-Cell / complications
  • Leukemia-Lymphoma, Adult T-Cell / drug therapy
  • Leukemia-Lymphoma, Adult T-Cell / immunology*
  • Leukemia-Lymphoma, Adult T-Cell / therapy
  • Middle Aged
  • Nitrosourea Compounds / administration & dosage
  • Prednisolone / therapeutic use
  • Prednisone / administration & dosage
  • Purpura, Thrombocytopenic, Idiopathic / complications
  • Purpura, Thrombocytopenic, Idiopathic / drug therapy
  • Purpura, Thrombocytopenic, Idiopathic / immunology*
  • Pyrazoles / therapeutic use
  • Remission, Spontaneous
  • Vincristine / administration & dosage
  • Vindesine / administration & dosage

Substances

  • Adrenal Cortex Hormones
  • Benzoates
  • Hydrazines
  • Nitrosourea Compounds
  • Pyrazoles
  • Vincristine
  • Etoposide
  • Doxorubicin
  • Cyclophosphamide
  • Prednisolone
  • Carboplatin
  • Vindesine
  • ranimustine
  • eltrombopag
  • Prednisone

Supplementary concepts

  • CHOP protocol